Meta-Analysis
Copyright ©The Author(s) 2021.
World J Orthop. Jan 18, 2021; 12(1): 35-50
Published online Jan 18, 2021. doi: 10.5312/wjo.v12.i1.35
Table 3 Mortality and complications in hip-fractured patients treated during coronavirus disease 2019 and pre-coronavirus disease 2019 times (2020)
Study/country
Macey et al[9]/United Kingdom
Malik-Tabassum et al[38]/United Kingdom
Segarra et al[27]/Spain
Thakrar et al[19]/United Kingdom
Egol et al[20]/United States
Williams et al[28]/United Kingdom
Slullitel et al[39]/Argentina
Karayiannis et al[29]/United Kingdom
30-d mortalityPre-COVID10 (13%)12 (6.89%)9 (12.9%)6 (6.06%)3 (2.7%)1 (6.6%)016 (6%)
COVID11 (14%)6 (8.8%)8 (11.8%)7 (16.3%)17 (12.3%)2 (13.3%)8 (10.8%)7 (3.4%)
COVID +2 (20%)1 (100%)NM4 (33%)9 (52.9%) + 2 (14.3%); Total-11 (35.4%)NMNM4 (57.14%)
COVID −9 (13.6%)5 (7.4%)NM3 (9.6%)6 (5.6%)NMNM3 (42.86%)
In-patient mortalityPre-COVIDNM11 (6.32%)NMNM1 (0.9%)NMNMNM
COVIDNM4 (5.9%)NMNM8 (5.8%)NMNMNM
Length of hospital stay (d)Pre-COVIDMedian: 12 (range, 7-26); 1mean: 14.25 ± 3.172018: 15.8 ± 11.4; 2019: 16.3 ± 11.4NMNM5.8 ± 3.711.7Median: 5 (IQR, 4-7); 1mean: 5.35 ± 2.26NM
COVIDMedian: 11.5 (range, 6-22); 1mean: 12.75 ± 2.678.6 ± 4.6NMNM5.8 ± 3.86.2Median: 6 (IQR, 5-8); 1mean: 6.35 ± 2.26NM
Major complicationsPre-COVID11 (14.5%)17 (9.7%)NMNM10 (8.7%)NM10 (11.6%)NM
COVID17 (22.4%)3 (4.5%)NMNM28 (20.3%)NM16 (21.6%)NM
Pulmonary complications/pneumonia/ respiratory infectionPre-COVID8 (10.95%)NMNMNMNM2 (13.3%)2 (2.32%)NM
COVID 15 (20.54%)NMNMNMNM00NM
Deep vein thrombus/pulmonary embolismPre-COVID1 (1.36%)2 (1.14%)NMNMNMNM0NM
COVID01 (1.47%)NMNMNMNM5 (6.75%)NM